Adicon Holdings (HKSE:09860) Notes Receivable: HK$0 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:09860 Adicon Holdings Ltd HKSE:09860
73 GF Score
Price HK$3.48
GF Value HK$7.25
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Adicon Holdings Notes Receivable?

Adicon Holdings HKSE:09860 -5.56% 73 Notes Receivable is HK$0 Mil as of Dec. 2025. GuruFocus rates HKSE:09860 with a GF Score™ of 73/100 and a GF Value™ of HK$7.25 (Possible Value Trap). The stock has 6 warning signs investors should review.

Adicon Holdings's Notes Receivable for the quarter that ended in Dec. 2025 was HK$0 Mil.

Adicon Holdings Notes Receivable Related Terms

Adicon Holdings Notes Receivable Historical Data

* Premium members only.

The historical data trend for Adicon Holdings's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Adicon Holdings Notes Receivable Chart

Adicon Holdings Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Adicon Holdings Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:09860
73GF Score
Adicon Holdings Ltd HKSE:09860
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Adicon Holdings Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of HK$0 Mil mean?
Adicon Holdings (HKSE:09860) has a Notes Receivable of HK$0 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Adicon Holdings and its competitors.
Is Adicon Holdings' Notes Receivable too high?
Adicon Holdings' current Notes Receivable is HK$0 Mil. Overall, Adicon Holdings has a GF Score™ of 73/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Adicon Holdings' Notes Receivable compare to TMO and DHR?
Adicon Holdings' Notes Receivable of HK$0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Medical Diagnostics & Research company?
A good Notes Receivable depends on the Medical Diagnostics & Research industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Adicon Holdings and its competitors. Adicon Holdings's current Notes Receivable is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Adicon Holdings stock overvalued right now?
Based on GuruFocus' analysis, Adicon Holdings (HKSE:09860) is currently considered Possible Value Trap. The stock's GF Value™ is HK$7.25, compared to a current price of HK$3.48 — trading 52% below its estimated fair value. The current Notes Receivable is HK$0 Mil. Adicon Holdings' overall GF Score™ is 73/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Adicon Holdings (HKSE:09860), the current Notes Receivable is HK$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Adicon Holdings (HKSE:09860) Overvalued in 2026?

Based on GuruFocus' analysis, Adicon Holdings stock appears to be undervalued. The current stock price of HK$3.48 is trading 52% below its estimated GF Value™ of HK$7.25. GuruFocus considers Adicon Holdings to be Possible Value Trap.

Key valuation signals for HKSE:09860:

  • Notes Receivable: HK$0 Mil
  • GF Value™: HK$7.25 vs. price of HK$3.48 (52% below fair value)
  • GF Score™: 73/100 with 6 warning signs

No single metric tells the full story. See the HKSE:09860 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Adicon Holdings Business Description

Address No. 208, Zhenzhong Road, West Lake District, Xihu District, Hangzhou, CHN
Adicon Holdings Ltd is a ICL service provider in China. It offers comprehensive testing services to hospitals and health check centers through an integrated network of self-operated laboratories across China. Its testing services platform includes clinical laboratories, pathology laboratories, reproductive genetics laboratories, gene laboratories, and mass spectrometry laboratories, consisting of over 4,000 medical diagnostic tests, the introduction of over 300 new high-end diagnostic tests.
73GF Score

Get the complete analysis for HKSE:09860

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$3.48
Price
HK$7.25
GF Value